AETHLON MEDICAL INC vs. ResMed Inc.
ResMed Inc. (RMD) comes out ahead, leading on 7 of 8 compared factors.
Size & Scale
| AEMD | RMD | |
|---|---|---|
| Market Cap | $1.62 million | $34.00 billion |
| Revenue (TTM) | $759 | $5.65 billion |
| Net Income (TTM) | $-6,937,523 | $1.52 billion |
RMD leads on 3 of 3 size & scale factors.
Valuation
| AEMD | RMD | |
|---|---|---|
| P/E Ratio | — | 22.60 |
| Price / Book | 0.31 | 5.16 |
| Price / Sales | 2136.22 | 6.01 |
AEMD and RMD split the valuation factors evenly.
Profitability
| AEMD | RMD | |
|---|---|---|
| Net Margin | -914034.65% | 26.94% |
| Return on Equity | -133.43% | 23.13% |
RMD leads on 2 of 2 profitability factors.
Dividend
| AEMD | RMD | |
|---|---|---|
| Dividend Yield | — | 1.12% |
| Payout Ratio | — | 25.31 |
AEMD and RMD split the dividend factors evenly.
Risk & Sentiment
| AEMD | RMD | |
|---|---|---|
| Short Interest | 176.25% | 4.04% |
RMD leads on 1 of 1 risk & sentiment factors.
Dig deeper: AEMD overview, AEMD financials, RMD overview, RMD financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.